Latest GlaxoSmithKline Stories

GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive

2013-04-05 12:24:48

- 208,000 square foot building houses 1,300 employees - and not a single office PHILADELPHIA, April 5, 2013 /PRNewswire/ -- GlaxoSmithKline (@GSKUS) officially opens its new double LEED® platinum certified facility in Philadelphia's Navy Yard Corporate Center this Saturday, ushering in a new era of how people work in Philadelphia. Employees, families and friends will celebrate and attend a ribbon-cutting ceremony with GSK President of North America Pharmaceuticals Deirdre Connelly,...

Covis Pharmaceuticals, Inc Named US Distributor For Five Additional Products

2013-04-05 08:23:20

Drugs Include Nilandron®, Plaquenil®, Rilutek®, Uroxatral®, and Kayexalate® CARY, N.C., April 5, 2013 /PRNewswire/ -- Covis Pharmaceuticals, Inc. announced an agreement today to distribute Nilandron(®) (nilutamide), Plaquenil(®) (hydroxychloroquine), Rilutek(®) (riluzole), Uroxatral(®) (alfuzosin hydrochloride) and Kayexalate(®) (sodium polystyrene sulfate) in the United States.The products cover a broad array of treatments and disease states: Nilandron is used to treat...

Valeant Pharmaceuticals Provides Update to Recent Event

2013-04-04 08:28:37

MONTREAL, April 4, 2013 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today responded to a generic approval for Zovirax® ointment. "Yesterday, Mylan announced they had received approval of a generic Zovirax® ointment," stated J. Michael Pearson. "While the timing of a generic approval was always uncertain, this was not unforeseen and we were prepared for its eventuality. In response to the new generic approval, we will be launching an...

Statement from GlaxoSmithKline Consumer Healthcare on FDA Report Regarding FDA's Changes to the Labeling of Over-the-Counter Nicotine Medications

2013-04-01 16:24:11

PARSIPPANY, N.J., April 1, 2013 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today announced a recommendation to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy (NRT) products. As leaders in smoking cessation, GlaxoSmithKline (GSK) Consumer Healthcare commends the FDA on this action and believes this is a positive step to help more smokers quit and will work with the FDA to implement these changes to...

2013 Paxil Birth Defect Allegation Cases Now Being Investigated by Resource4thePeople Attorneys

2013-03-31 23:04:09

Lawyers will review increasing numbers of consumer inquiries generated by recent medical research study raising concerns about alleged links between anti-depressant side effects and birth defects. San Diego, CA (PRWEB) March 31, 2013 http://www.resource4thepeople.com/defectivedrugs/paxil.html Resource4thePeople announced today that its lawyers are now investigating 2013 cases from families who are inquiring about whether alleged birth defects suffered by their infants may have been caused...

Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas

2013-03-26 12:29:23

Team will develop and manufacture GSK's next generation influenza vaccines to protect the nation against global pandemics AUSTIN, Texas and PHILADELPHIA, March 26, 2013 /PRNewswire/ -- GlaxoSmithKline plc (GSK) and The Texas A&M University System announced today that the U.S. Department of Health and Human Services (DHHS) has approved the establishment of a $91 million influenza-vaccines manufacturing facility as the anchor of the Center for Innovation in Advanced Development and...

Einstein Study Reveals New Approach for Stopping Herpes Infections

2013-03-25 16:25:01

BRONX, N.Y., March 25, 2013 /PRNewswire-USNewswire/ -- Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered a novel strategy for preventing infections due to the highly common herpes simplex viruses, the microbes responsible for causing genital herpes (herpes simplex virus 2) and cold sores (herpes simplex virus 1). The finding, published online by The FASEB Journal, could lead to new drugs for treating or suppressing herpes virus infections....

infirst HEALTHCARE to Commercialise Novel Consumer Healthcare Drugs

2013-03-25 08:26:29

LONDON, March 25, 2013 /PRNewswire/ -- GBP25 Million Fundraising for Fast-to-Market Medicines infirst HEALTHCARE, the consumer healthcare company commercialising unique, fast-to-market consumer medicines, today announces it has successfully raised GBP25 million of new funds. The funding, from Invesco Asset Management managed funds, will be used for the launch of the company's medicines into the US$20 billion cough & cold and pain consumer healthcare markets where...

Heart Beats: Lawyers at Console & Hollawell Weigh in on the FDA’s New Warning Against Zithromax

2013-03-22 23:01:13

A year-old report from the New England Journal of Medicine has prompted the U.S. Food and Drug Administration to warn doctors and patients about sharply increased heart risks when taking the popular antibiotic azithromycin, more commonly known as Zithromax or Z-Pak. In Philadelphia, personal injury attorney Richard P. Console Jr. wonders what this new federal alert could mean for patients who’ve already suffered a severe reaction to Zithromax. Marlton, NJ (PRWEB) March 22, 2013 A...

Superior Court Affirms Granting Summary Judgment in Paxil Birth Defect Case: Now, AttorneyOne Can Provide Advice

2013-03-21 23:03:53

According to court documents, on March 4th, 2013, the Pennsylvania Supreme Court affirmed an order of Philadelphia Court granting summary judgment in Paxil birth defect case. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by alleged Paxil side effects. San Diego, CA (PRWEB) March 21, 2013 AttorneyOne.com, a recognized authority on law, updated...